Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report

Tekijä Biersack Hans-Jürgen, Wilinek Winfried, Herrlinger Ulrich, Ahmadzadehfar Hojjat, Sabet Amir, Ezziddin Samer
Julkaistu 2011-08-01

Successful radiopeptide targeting of metastatic anaplastic meningioma: Case report

Tekijä Sabet, Amir, Ahmadzadehfar, Hojjat, Herrlinger, Ulrich, Wilinek, Winfried, Biersack, Hans-Jürgen, Ezziddin, Samer
Julkaistu 2011

Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of (131)I-MIBG

Tekijä Ezziddin, Samer, Sabet, Amir, Ko, Yon-Dschun, Xun, Sunny, Matthies, Alexander, Biersack, Hans-Jürgen
Julkaistu 2012

May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreo...

Tekijä Sabet, Amir, Khalaf, Feras, Mahjoob, Soha, Al-Zreiqat, Abdullah, Biersack, Hans-Jürgen, Ezziddin, Samer
Julkaistu 2013

Does PRRT with standard activities of (177)Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor...

Tekijä Sabet, Amir, Nagarajah, James, Dogan, Ahmet Semih, Biersack, Hans-Jürgen, Sabet, Amin, Guhlke, Stefan, Ezziddin, Samer
Julkaistu 2013

Efficacy of peptide receptor radionuclide therapy with (177)Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysis

Tekijä Sabet, Amir, Haug, Alexander R, Eiden, Collin, Auernhammer, Christoph J, Simon, Birgit, Bartenstein, Peter, Biersack, Hans J, Ezziddin, Samer
Julkaisussa Am J Nucl Med Mol Imaging (2017)

Quantitative performance of (124)I PET/MR of neck lesions in thyroid cancer patients using (124)I PET/CT as reference

Tekijä Jentzen, Walter, Phaosricharoen, Jinda, Gomez, Benedikt, Hetkamp, Philipp, Stebner, Vanessa, Binse, Ina, Kinner, Sonja, Herrmann, Ken, Sabet, Amir, Nagarajah, James
Julkaisussa EJNMMI Phys (2018)

Bone metastases in GEP-NET: response and long-term outcome after PRRT from a follow-up analysis

Tekijä Sabet, Amir, Khalaf, Feras, Haslerud, Torjan, Al-Zreiqat, Abdullah, Sabet, Amin, Simon, Birgit, Pöppel, Thorsten D, Biersack, Hans-Jürgen, Ezziddin, Samer
Julkaistu 2013

Hematologic safety of (177)Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

Tekijä Groener, Daniel, Nguyen, Cam Tu, Baumgarten, Justus, Bockisch, Benjamin, Davis, Karen, Happel, Christian, Mader, Nicolai, Nguyen Ngoc, Christina, Wichert, Jennifer, Banek, Severine, Mandel, Philipp, Chun, Felix K. H., Tselis, Nikolaos, Grünwald, Frank, Sabet, Amir
Julkaisussa EJNMMI Res (2021)